Leading the way to safer medication
 Crosscheck  Recommender

Moxifloxacin

Description

Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair.

ATC Classification

Code
Title
Category
J01MA14
Moxifloxacin
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
S01AE07
Moxifloxacin
S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AE Fluoroquinolones

Trade names

Trade name
Countries

Spain

Spain

Spain

Austria Cyprus Singapore United Kingdom

Cyprus Spain

Singapore

France

Singapore

Singapore

Singapore

Singapore

United States

United Kingdom

Canada Cyprus Netherlands Singapore Spain

Product Monographs

Monograph
Type
Country
AVELOX Solution for infusion
MPI, EU: SmPC
UK
AVELOX Film-coated tablets
MPI, EU: SmPC
UK
MOXIVIG Eye drops (solution)
MPI, EU: SmPC
UK